Skip to main content

Kezar Life Sciences, Inc.

KZRDelisted May 11, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001645666

Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Kezar Life Sciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Kezar Life Sciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Kezar Life Sciences, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Berger Franklin MDirector0May 11, 20261
Kauffman MichaelDirector0May 11, 20261
Belsky MarcChief Financial Officer0IndirectMay 11, 20261
Cooper Graham KDirector–May 11, 20261
Garner ElizabethDirector–May 11, 20261
Kirk Christopher J.CEO0May 11, 20261
Fowler John FranklinDirector0IndirectMay 11, 20261
Wallace CourtneyDirector–May 11, 20261
Klearman MickiDirector–May 11, 20261
Schiller Mark C.Chief Operating Officer0May 11, 20261
Chiang Pichi LuoSVP, Corporate Controller0May 11, 20261
To Zung PhuongChief Development Officer–Jul 1, 20250
Mordwinkin Nicholas MichaelChief Business Officer–Jan 9, 20240
Morningside Venture Investments Ltd10% Owner1,947,993Aug 17, 20230
Henig NoreenChief Medical Officer–Jul 26, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 3, 2025 (view filing)Jul 21 dayChiang Pichi LuoSVP, Corporate ControllerSSale−264$4.28−$1.13K−8.9%2.71K after
Jul 3, 2025 (view filing)Jul 21 daySchiller Mark C.Chief Operating OfficerSSale−561$4.28−$2.40K−17.0%2.74K after
Jul 26, 2024 (view filing)Jul 224 daysLateSchiller Mark C.Chief Legal OfficerSSale−6.69K$0.58−$3.88K−16.8%33.0K after
Feb 7, 2023 (view filing)Feb 3-64 daysMorningside Venture Investments Ltd10% OwnerSSale−65.0K$6.98−$453.9K−1.2%5.45M after2 lots
Feb 3, 2023 (view filing)Feb 1-22 daysMorningside Venture Investments Ltd10% OwnerSSale−90.0K$7.08−$637.5K−1.6%5.51M after2 lots
Feb 1, 2023 (view filing)Jan 30-312 daysMorningside Venture Investments Ltd10% OwnerSSale−60.0K$7.00−$419.7K−1.1%5.60M after2 lots
Jan 27, 2023 (view filing)Jan 252 daysMorningside Venture Investments Ltd10% OwnerSSale−50.0K$6.85−$342.5K−0.9%5.66M after
Jan 25, 2023 (view filing)Jan 23-242 daysMorningside Venture Investments Ltd10% OwnerSSale−160.0K$6.90−$1.10M−2.7%5.71M after2 lots
Jan 19, 2023 (view filing)Jan 172 daysMorningside Venture Investments Ltd10% OwnerSSale−6.11K$6.79−$41.5K−0.1%5.87M after
Jan 17, 2023 (view filing)Jan 12-135 daysMorningside Venture Investments Ltd10% OwnerSSale−6.97K$6.88−$47.9K−0.1%5.88M after2 lots
Jan 9, 2023 (view filing)Jan 5-64 daysMorningside Venture Investments Ltd10% OwnerSSale−15.2K$6.95−$105.4K−0.3%5.89M after2 lots
Jan 5, 2023 (view filing)Dec 29, 2022-Jan 4, 20237 daysLateMorningside Venture Investments Ltd10% OwnerSSale−55.5K$7.14−$396.1K−0.9%5.90M after3 lots
Oct 5, 2022 (view filing)Oct 3-42 daysMorningside Venture Investments Ltd10% OwnerSSale−32.3K$8.78−$283.8K−0.5%6.08M after2 lots
Mar 22, 2022 (view filing)Mar 18-214 daysBerger Franklin MDirectorPPurchase+80.0K$16.25+$1.30M+9.9%890.7K after3 lots
Jan 5, 2022 (view filing)Jan 32 daysKauffman MichaelDirectorSSale−5.00K$16.45−$82.3K−7.3%63.7K after